Multiple myeloma is a type of cancer that affects certain white blood cells, called plasma cells, in the bone marrow. The condition can cause people to feel unwell and extremely tired. It can also affect their bones and other organs, such as the kidneys.
The American Cancer Society estimates that in the United States, doctors will diagnose multiple myeloma in 19,320 men and 15,600 women in 2021. Researchers are continually working on new treatments to extend life expectancy for people with this condition.
Multiple myeloma treatment has come a long way since the days when chemotherapy was the only option. Today, more therapies exist than ever before.
Doctors can now customize a treatment plan for each person based on their diagnosis and unique needs. Options may include chemotherapy with stem cell transplantation, immunotherapy drugs, targeted therapies, and novel drug combinations.
This article looks at multiple myeloma treatment options, including chemotherapy and other drugs, bone marrow transplants, and radiation therapy. It also looks at a persons possible outlook following a multiple myeloma diagnosis.
Multiple myeloma is a type of cancer that changes someones plasma cells. These specialized cells are typically located in the bone marrow, and they play an essential role in the immune system.
If a person has multiple myeloma, the altered, cancerous plasma cells build up in the bone marrow, which means that there is not enough space for healthy blood cells. Instead of making antibodies that protect an individual from invading germs, the cancerous cells make an abnormal protein called monoclonal immunoglobulin, or monoclonal protein (M-protein).
Doctors may find these elevated M-proteins while testing the blood for another condition. They may also make a diagnosis because they suspect that someone has multiple myeloma based on their symptoms.
Although there are no specific causes of multiple myeloma, it appears to be more common among males, Black people, and individuals aged 45 years and above.
When treating multiple myeloma, doctors typically use chemotherapy to prepare the body for a stem cell transplant.
Chemotherapy is a powerful form of treatment that kills cells that divide and multiply quickly, such as cancer cells. However, healthy cells that grow rapidly may also become chemotherapy targets. This includes cells in the bone marrow, digestive tract, reproductive system, and hair follicles.
When chemotherapy damages healthy cells, it can cause side effects, including:
People undergoing chemotherapy may also develop low blood counts as a side effect of treatment. Having a low blood count means that an individual has an increased risk of infection. They bruise and bleed more easily, feel fatigued, and could be short of breath.
Most chemotherapy side effects disappear once a person has completed treatment.
Monoclonal antibodies are a form of immunotherapy that uses someones immune system to fight the cancer cells by targeting specific proteins. Some monoclonal antibodies target the CD38 protein, while others target the SLAM57 protein. Myeloma cells have both proteins.
Monoclonal antibodies affect cancer cells directly and help the immune system attack them. Doctors often use this treatment in combination with other types of drugs.
These drugs can cause a reaction at the time of administration or a few hours after. Some symptoms of a reaction include:
Immunomodulating drugs regulate certain aspects of the immune system. They can prevent some types of growth signals for cancer cells, activate specific immune cells, and kill myeloma cells.
The first immunomodulating drug that researchers developed was called thalidomide, and it caused severe congenital disabilities. Researchers still question the safety of newer immunomodulating drugs related to thalidomide, and people can only receive them through special programs.
The side effects of immunomodulating drugs depend on the specific drug but can include:
Steroids are an essential treatment for all stages of multiple myeloma. At high doses, steroids can kill cancer cells. They can also stop white blood cells from going to the disease-affected areas, thereby decreasing inflammation and relieving pain and pressure.
Some side effects of steroids include:
Long-term steroid use may suppress the immune system and weaken the bones. However, these side effects often go away once the steroid treatment is over.
People with myeloma can develop weak bones that may break easily. Bone modifying drugs called bisphosphonates can help strengthen the bones and slow down the weakening process. They can also reduce pain levels.
One rare but severe side effect of bone modifying drugs is osteonecrosis of the jaw. The drugs can destroy the jawbone and create an open wound that cannot heal. The open sore can lead to infection, and some people also experience tooth loss in the area.
One way to prevent this is by maintaining good oral hygiene and treating tooth or gum infections right away.
The standard of care for those with multiple myeloma involves a combination of high-dose chemotherapy and a bone marrow transplant. Getting a bone marrow transplant often means that an individual remains disease-free for a long time.
Whether or not someone is a good candidate for a bone marrow transplant depends on many factors, such as their age and the stage of their myeloma.
People frequently receive chemotherapy before a bone marrow transplant, which weakens their immune system and can lead to infections.
Some other side effects of bone marrow transplants can include:
Radiation therapy uses rays of particles to damage multiple myeloma cells and prevent them from growing. Not only can radiation therapy treat multiple myeloma, but it can also reduce complications from bone disease.
Like chemotherapy, radiation therapy can damage some normal cells, especially those that divide quickly. However, most healthy cells recover fully from the effects of radiation therapy.
Some side effects of radiation therapy include fatigue and a loss of appetite. A person may also have some sensitivity and irritation in the skin around the treatment area.
Doctors cannot cure multiple myeloma. There are times when it may lie dormant, but the cancer usually returns. For some people, multiple myeloma may present with no symptoms and progress slowly. A good response to initial treatment can lead to a promising outlook.
Even when treatment is over, regular follow-up testing is necessary to monitor for relapse. The 5-year survival rate for multiple myeloma in 20102016 was 53.9%. This rate has been steadily increasing.
Multiple myeloma is a cancer that affects the plasma cells in the bone marrow. There are many treatment options for multiple myeloma.
The standard of care is a combination of chemotherapy and radiation therapy. In most cases, treatment includes a combination of multiple therapies and drugs.
Multiple myeloma has no cure, but people can go into remission. People in remission must have regular follow-up testing to monitor for disease recurrence.
See the original post:
Multiple myeloma treatment: Newest options, drugs, and more - Medical News Today
- New Atlas of Rare Stem and Progenitor Cells Reveals New Cell Types - Inside Precision Medicine - March 28th, 2024
- Instructing iPS cell-derived mesenchymal stem cells to inhibit abnormal bone formation in FOP - Medical Xpress - March 28th, 2024
- GLP podcast: GE crops have lived up to the hype; Growing 'mini' organs from stem cells; How do we solve right-wing ... - Genetic Literacy Project - March 28th, 2024
- Exosomes and Stem Cells Are the Future of Anti-Aging - NewBeauty Magazine - March 28th, 2024
- Stem cells: past, present, and future - PMC - National Center for ... - March 19th, 2024
- Stem cells: a comprehensive review of origins and emerging clinical ... - March 19th, 2024
- Biology of stem cells: an overview - PMC - National Center for ... - March 19th, 2024
- What are Stem Cells? - Types, Applications and Sources - BYJU'S - March 19th, 2024
- Stem Cell - The Definitive Guide | Biology Dictionary - March 19th, 2024
- Colossal Creates Elephant Stem Cells for the First Time in Quest to Revive the Woolly Mammoth - Singularity Hub - March 19th, 2024
- Florida congresswoman sued the Pentagon over stem cells. One problem: her husband's stocks - Raw Story - January 23rd, 2024
- Can Stem Cells Improve Knee Pain or Are They A Waste of Money? - Bloomberg - January 23rd, 2024
- Stem cells used to successfully treat arthritis in gorilla at Budapest zoo - University of Sheffield News - January 23rd, 2024
- A computational model of stem cells' internal mechanism to recapitulate spatial patterning and maintain the self ... - Nature.com - January 23rd, 2024
- Advancing the generation of in-vivo chimeric lungs in mice using rat-derived stem cells - EurekAlert - January 6th, 2024
- 'I couldn't just give up on my dad' | Round Rock son donates stem cells to father battling leukemia - KVUE.com - January 6th, 2024
- Closing in on the ultimate quest to regenerate insulin in pancreatic stem cells - Medical Xpress - January 6th, 2024
- Ask the doctors: Research being conducted on using stem cells to treat diabetes - The Spokesman Review - January 6th, 2024
- Regenerative Medicine and COPD: Generating Functional Lungs from Pluripotent Stem Cells - Medriva - January 6th, 2024
- What is a stem cell? YourGenome - December 2nd, 2023
- Stem cell transplant - NHS - December 27th, 2022
- Stem cells: a brief history and outlook - Science in the News - December 27th, 2022
- RUDN Physician And Russian Scientists Investigate Long-term Effects Of Treating Diabetic Ulcers With Stem Cells - India Education Diary - December 27th, 2022
- Stem Cell Basics | STEM Cell Information - National Institutes of Health - December 2nd, 2022
- Neural stem cell - Wikipedia - November 24th, 2022
- Donate Stem Cells | Bone Marrow Donation - American Cancer Society - November 24th, 2022
- Stem Cells- Definition, Properties, Types, Uses, Challenges - November 6th, 2022
- Brothers from Karnataka, Prapul and Prajwal donated their stem cells, save two blood cancer patients - APN News - November 6th, 2022
- Getting These Stem Cells Treatments: Crippled Ronnie Coleman Gives a Positive Update on His Ability to Walk - EssentiallySports - October 21st, 2022
- Cornell Prof Explains Relevance of Creating Mouse Embryos from Stem Cells - Cornell University The Cornell Daily Sun - October 13th, 2022
- Human neuron clusters transplanted into rats offer new tool to study the brain : Shots - Health News - NPR - October 13th, 2022
- The neuroprotective effects of dental pulp stem cells and erythropoietin in mice hippocampus after ischemia-reperfusion - Newswise - October 13th, 2022
- A $7 million grant to grow stem cell research - Swinburne University of Technology - October 13th, 2022
- Stem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Management, Personalized Medicine, and Genome... - October 13th, 2022
- Brennand named Elizabeth Mears and House Jameson Professor of Psychiatry - Yale News - October 13th, 2022
- American Academy of Stem Cell Physicians to Offer Licensed Physicians Board Examination in Regenerative Medicine - BioSpace - October 13th, 2022
- Stem Cells - alsa.org - October 4th, 2022
- Mouse embryo models built from stem cells take shape in a dish - Nature.com - October 4th, 2022
- Growth in Cell and Gene Therapy Market - Pharmaceutical Technology Magazine - October 4th, 2022
- Therapeutic Solutions International Identifies CD103 Expressing Dendritic Cells and Exosomes Thereof as Novel Mechanism for JadiCell Mesenchymal Stem... - October 4th, 2022
- Aileron Therapeutics Announces Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from... - October 4th, 2022
- Research Shows Promise for Directing Later Lines of Therapy for Hodgkin Lymphoma - Targeted Oncology - October 4th, 2022
- Hereditary E200K mutation within the prion protein gene alters human iPSC derived cardiomyocyte function | Scientific Reports - Nature.com - September 25th, 2022
- How To Eat Your Way to Better Health According to a Doctor - Eat This, Not That - September 25th, 2022
- Phio Pharmaceuticals Announces Preclinical Data Demonstrating PH-762 Enhances Persistence of T cells for Tumor Cell Killing as Presented by Helmholtz... - September 25th, 2022
- Types of blood cancer: Leukemia, lymphoma, and more - Medical News Today - September 25th, 2022
- September: er-blood | News and features - University of Bristol - September 25th, 2022
- Here Is Why You Heal Slower As You Age - Health Digest - September 25th, 2022
- Global Single Cell Analysis Market is Projected to Grow at a CAGR of 15.1% By 2032: Visiongain Reports Ltd - Yahoo Finance UK - September 25th, 2022
- Findings explain exceptional auditory abilities in Williams-Beuren Syndrome - EurekAlert - September 25th, 2022
- Finding the potency in planarians | Communications Biology - Nature.com - September 16th, 2022
- Life-Saving Innovations in Cancer-Fighting Stem Cell Transplants and Pioneering Research in HIV, Autism and Cerebral Palsy to be Featured at World... - September 16th, 2022
- Treating Cancer with Oncolytic Viruses - BioPharm International - September 16th, 2022
- Israel's Profuse Technology Raises $2.5M for Technology That Lowers Cost of Cultured Meat - The Spoon - September 16th, 2022
- Stem Cells Used to Grow Mouse Embryo - BioTechniques - September 8th, 2022
- Largest Gift in UCSD History to Fund Stem Cell Research on Space Station - Times of San Diego - September 8th, 2022
- Global Induced Pluripotent Stem Cells Market (2022 to 2027) - Growth, Trends, Covid-19 Impact and Forecasts - ResearchAndMarkets.com - Business Wire - September 8th, 2022
- Health on the Frontlines: The Healing Power of Stem Cells - Dans Papers - September 8th, 2022
- Top 3 grants in regenerative medicine: July 2022 - RegMedNet - September 8th, 2022
- Childhood leukemia treatment 2022: Where we are now and what it takes - EurekAlert - September 8th, 2022
- Treatment Choices for AML Were Increasingly Influenced by Immunological Responses - Physician's Weekly - September 8th, 2022
- BioRestorative Therapies to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14 - StreetInsider.com - September 8th, 2022
- Global Recombinant Cell Culture Supplements Market Report 2022: Increasing Need for Immunotherapies and Stem Cell and Regenerative Medicines Presents... - September 8th, 2022
- CAR-T Beyond CGTs In Development In 2022 - BioProcess Online - September 8th, 2022
- ADOCIA Announces First Cell Therapy Preclinical Proof of Concept of AdoShell Islets for the Treatment of Type 1 Diabetes - Business Wire - September 8th, 2022
- Synthetic Mouse Embryo with Brain and Beating Heart Grown from Stem Cells - Genetic Engineering & Biotechnology News - August 30th, 2022
- Utilization of Modified Induced Pluripotent Stem Cells as the Advance | OPTH - Dove Medical Press - August 30th, 2022
- Rise In Number Of CROS In Various Regions Such As Europe Is Expected To Fuel The Growth Of Induced Pluripotent Stem Cell Market At An Impressive CAGR... - August 30th, 2022
- Brush Up: Hematopoietic Stem Cells and Their Role in Development and Disease Therapy - The Scientist - August 30th, 2022
- Regenerative Properties of the Newborn Heart Offers Hope for Those With Congenital Heart Disease - The Epoch Times - August 30th, 2022
- Kanpur hospital is Indias first to perform fat-derived stem cell transplant for diabetic patients - India Today - August 30th, 2022
- Scientists Just Genetically Edited a Million Years of Evolution Into Mouse DNA - ScienceAlert - August 30th, 2022
- Canadian Blood Services Stem Cells for Life - August 22nd, 2022
- Scientists say they have created 'embryos' without sperm or eggs - Medical News Today - August 22nd, 2022
- Many stem cell lines used for research and therapies carry large number of mutations, Cambridge researchers find - Cambridge Independent - August 22nd, 2022
- Scientists hope to revive extinct mammal through stem cells and gene-editing in a first - The Mirror - August 22nd, 2022
- Stem cell therapy in capsule form - Malaya - August 22nd, 2022
- Cell Culture Technician Pluripotent Stem Cell Biology and Genome Editing job with UNIVERSITY OF SOUTHAMPTON | 305107 - Times Higher Education - August 22nd, 2022
- Long COVID-19 and other chronic respiratory conditions after viral infections may stem from an overactive immune response in the lungs - The... - August 5th, 2022
- Self-organized anteroposterior regionalization of early midbrain and hindbrain using micropatterned human embryonic stem cells - Newswise - July 27th, 2022